StockData
Sight Sciences, Inc. logo

Sight Sciences, Inc. (SGHT) stock

SGHTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30164% above fair value
$10.77+0.28 (+2.67%)

Close on Nov 18, 2026Market cap $593.30MP/E –Yield –

Sight Sciences total assets

Total assets on the balance sheet at the end of each period.

Sight Sciences's total assets was $104.87M at Jun 30, 2026. For fiscal 2025 it was $115.30M, down 19.3% from the year before. The highest annual figure on record is $280.19M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$115.30M-19.3%
FY2024Dec 31, 2024$142.84M-14.3%
FY2023Dec 31, 2023$166.65M-21.8%
FY2022Dec 31, 2022$213.07M-24.0%
FY2021Dec 31, 2021$280.19M+284.8%
FY2020Dec 31, 2020$72.81M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$104.87M-14.0%
Q1 FY2026Mar 31, 2026$109.70M-15.4%
Q4 FY2025Dec 31, 2025$115.30M-19.3%
Q3 FY2025Sep 30, 2025$116.26M-19.0%
Q2 FY2025Jun 30, 2025$121.97M-18.5%
Q1 FY2025Mar 31, 2025$129.68M-16.6%
Q4 FY2024Dec 31, 2024$142.84M-14.3%
Q3 FY2024Sep 30, 2024$143.60M-18.7%
Q2 FY2024Jun 30, 2024$149.72M-19.2%
Q1 FY2024Mar 31, 2024$155.56M-20.9%
Q4 FY2023Dec 31, 2023$166.65M-21.8%
Q3 FY2023Sep 30, 2023$176.64M-21.6%
Q2 FY2023Jun 30, 2023$185.29M-23.0%
Q1 FY2023Mar 31, 2023$196.64M-24.0%
Q4 FY2022Dec 31, 2022$213.07M-24.0%
Q3 FY2022Sep 30, 2022$225.23M-22.6%
Q2 FY2022Jun 30, 2022$240.75M+358.5%
Q1 FY2022Mar 31, 2022$258.59M+255.2%
Q4 FY2021Dec 31, 2021$280.19M–
Q3 FY2021Sep 30, 2021$291.05M–
Q2 FY2021Jun 30, 2021$52.51M–
Q4 FY2020Dec 31, 2020$72.81M–

More Sight Sciences figures

See a number that looks wrong?